What is eXoZymes Inc. Common Stock's revenue?

eXoZymes Inc. Common Stock (EXOZ) generated $70.1K in revenue over the trailing twelve months.

Is eXoZymes Inc. Common Stock profitable?

eXoZymes Inc. Common Stock is not currently profitable: it reported a net loss of $9.7M over the trailing twelve months, a -2909.1% net margin.

What is eXoZymes Inc. Common Stock's earnings per share?

eXoZymes Inc. Common Stock's diluted EPS over the trailing twelve months is $-1.14.

Where does eXoZymes Inc. Common Stock's income statement data come from?

Every line is extracted from eXoZymes Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

eXoZymes Inc. Common Stock EXOZ Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	——	——	——	——	——
Research and development	$4.25M+14.7%	$3.71M+14.9%	$3.23M+18.1%	$2.73M+26.1%	$2.17M+15.9%
General and administrative	$5.9M-1.8%	$6.01M+4.0%	$5.78M+7.8%	$5.36M+13.9%	$4.71M+15.9%
Compensation and benefits	$3.85M+6.0%	$3.64M+7.3%	$3.39M+9.7%	$3.09M+12.3%	$2.75M+8.9%
Professional fees	$1.19M-17.7%	$1.44M-3.3%	$1.49M-2.1%	$1.52M+5.5%	$1.44M+23.6%
Total costs & expenses	$10.15M+4.5%	$9.72M+7.9%	$9M+11.2%	$8.09M+17.7%	$6.87M+15.9%
Operating income	-$10.15M-4.5%	-$9.72M-7.9%	-$9M-11.2%	-$8.09M-17.7%	-$6.87M-15.9%
Interest expense	$281.5K-22.3%	$362.09K+55.3%	$233.23K+6.6%	$218.69K+94.6%	$112.36K+44.8%
Other income (expense), net	——	——	——	——	——
Income before income taxes	-$9.78M-5.5%	-$9.26M-11.1%	-$8.34M-8.2%	-$7.71M-14.9%	-$6.71M-14.5%
Income tax expense	——	-$105.21K—	——	——	——
Net income	-$9.67M-5.6%	-$9.16M-9.8%	-$8.34M-8.2%	-$7.71M-14.9%	-$6.71M-14.5%
Diluted earnings per share	-$1.14-5.6%	-$1.08-5.9%	-$1.020.0%	-$1.02-6.3%	-$0.96-6.7%
Basic earnings per share	-$1.14-5.6%	-$1.08-5.9%	-$1.020.0%	-$1.02-6.3%	-$0.96-6.7%
Weighted-average shares, diluted	33.6M+0.3%	33.5M+5.7%	31.7M+7.2%	29.6M+7.7%	27.4M+8.4%
Weighted-average shares, basic	33.6M+0.3%	33.5M+5.7%	31.7M+7.2%	29.6M+7.7%	27.4M+8.4%
Interest Income (Expense), Nonoperating	$281.5K-22.3%	$362.09K-5.2%	$382.09K+37.3%	$278.26K+61.9%	$171.92K+122%
Data processing and equipment	$80.98K-15.6%	$95.99K+13.3%	$84.72K-8.1%	$92.2K+53.5%	$60.08K+55.4%
Other General and Administrative Expense	$779.09K-6.8%	$836.07K+2.4%	$816.22K+23.9%	$658.98K+45.3%	$453.52K+37.6%
Other income, net (Note 6)	——	——	——	——	——
EBIT	-$10.15M-4.5%	-$9.72M-7.9%	-$9M-11.2%	-$8.09M-17.7%	-$6.87M-15.9%
EBITDA	-$9.86M-4.6%	-$9.43M-8.1%	-$8.72M-11.6%	-$7.81M-18.4%	-$6.6M-16.5%
EBITDA	-$9.86M-4.6%	-$9.43M-8.1%	-$8.72M-11.6%	-$7.81M-18.4%	-$6.6M-16.5%
EBIT	-$10.15M-4.5%	-$9.72M-7.9%	-$9M-11.2%	-$8.09M-17.7%	-$6.87M-15.9%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about eXoZymes Inc. Common Stock.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is eXoZymes Inc. Common Stock's revenue?: eXoZymes Inc. Common Stock (EXOZ) generated $70.1K in revenue over the trailing twelve months.
Is eXoZymes Inc. Common Stock profitable?: eXoZymes Inc. Common Stock is not currently profitable: it reported a net loss of $9.7M over the trailing twelve months, a -2909.1% net margin.
What is eXoZymes Inc. Common Stock's earnings per share?: eXoZymes Inc. Common Stock's diluted EPS over the trailing twelve months is $-1.14.
Where does eXoZymes Inc. Common Stock's income statement data come from?: Every line is extracted from eXoZymes Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.